Objectives

After participating in this educational activity, attendees should be able to:
1| Identify common neurocognitive deficits experienced by individuals diagnosed with or at-risk for a serious mental illness (SMI).
2| Explain the relationship between neurocognition and social functioning in the early psychosis spectrum.
3| Discuss how neuropsychological evaluation can inform treatment planning for individuals on the psychotic spectrum.

Kaley Angers, PhD
Clinical Neuropsychologist
Columbia University Irving Medical Center
Instructor of Medical Psychology (in Psychiatry)

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Kaley Angers, PhDSpeakerNo relevant relationships with ineligible companies to discloseNo
Session date: 
02/03/2026 - 8:00am to 9:00am EST
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut 4
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 APA American Psychological Association
    Baystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
  • 1.00 ASWB Continuing Education Credit(s)
  • 1.00 IPCE Credit Hour(s)
  • 1.00 NBCC

    Baystate Health is an NBCC Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBCC requirements. The ACEP solely responsible for all aspects of the program. (ACEP #5684)

Please login or register to take this course.